Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections

Author:

Fahmi AliORCID,Palin VictoriaORCID,Zhong XiaominORCID,Yang Ya-Ting,Watts Simon,Ashcroft Darren M,Goldacre Ben,Mackenna Brian,Fisher Louis,Massey Jon,Mehrkar Amir,Bacon Seb,Hand Kieran,Staa Tjeerd Pieter van,

Abstract

AbstractBackgroundAntimicrobial resistance (AMR) is a multifaceted global challenge, partly driven by inappropriate antibiotic prescribing. The COVID-19 pandemic impacted antibiotic prescribing for common bacterial infections. This highlights the need to examine risk of hospital admissions related to common infections, excluding COVID-19 infections during the pandemic.MethodsWith the approval of NHS England, we accessed electronic health records from The Phoenix Partnership (TPP) through OpenSAFELY platform. We included patients with primary care diagnosis of common infections, including lower respiratory tract infection (LRTI), upper respiratory tract infections (URTI), and lower urinary tract infection (UTI), from January 2019 to August 2022. We excluded patients with a COVID-19 record 90 days before to 30 days after the infection diagnosis. Using Cox proportional-hazard regression models, we predicted risk of infection-related hospital admission in 30 days follow-up period after the diagnosis.ResultsWe found 12,745,165 infection diagnoses from January 2019 to August 2022. Of them, 80,395 (2.05%) cases were admitted to hospital in the follow-up period. Counts of hospital admission for infections dropped during COVID-19, e.g., LRTI from 3,950 in December 2019 to 520 in April 2020. Comparing those prescribed an antibiotic to those without, reduction in risk of hospital admission were largest with LRTI (adjusted odds ratio (OR) of 0.35; 95% CI, 0.35-0.36) and UTI (adjusted OR 0.45; 95% CI, 0.44-0.46), compared to URTI (adjusted OR 1.04; 95% CI, 1.03-1.06).ConclusionLarge effectiveness of antibiotics in preventing complications related to LRTI and UTI can support better targeting of antibiotics to patients with higher complication risks.Key messages- The main drivers of infection-related hospital admission are age, Charlson comorbidity index, and history of prior antibiotics.- Antibiotics are more effective in preventing hospital admission related to infections such as lower respiratory tract infection and urinary tract infection, rather than upper respiratory tract infection.- Common antibiotic types are associated with more reduction in the risk of infection-related hospital admission.

Publisher

Cold Spring Harbor Laboratory

Reference42 articles.

1. Sugden R , Kelly R , Davies S. Combatting antimicrobial resistance globally. Nat Microbiol. Macmillan Publishers Limited; 2016;1(10).

2. Ashiru-Oredope D , Hopkins S , ESPAUR Oversight Group Writing Committee. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR): Report 2020 to 2021. Public Heal Engl Publ [Internet]. 2021;1–209. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1069632/espaur-report-2020-to-2021-16-Nov-FINAL-v2.pdf

3. Development and validation of a multivariable prediction model for infection-related complications in patients with common infections in UK primary care and the extent of risk-based prescribing of antibiotics. BMC Med;BMC Medicine,2020

4. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves;Clin Microbiol Infect [Internet],2021

5. Silva TM , Estrela M , Gomes ER , et al. The impact of the covid-19 pandemic on antibiotic prescribing trends in outpatient care: A nationwide, quasi-experimental approach. Antibiotics. 2021;10(9).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3